Cian Healthcare Share Price
22.18+0.43 (+1.98%)
+392.89% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
CHCL-MTNSE
Cian Healthcare Share Price
22.18+0.43 (+1.98%)
+392.89% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | -12% | -27% | -50% |
| - | - | - | -3161% |
| - | 0% | -3% | 383% |
| -18% | -20% | -29% | -94% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
MANKIND-A
DRREDDY-A
AUROPHARMA-A
LUPIN-A
CHCL-MT
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,853 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,613 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,935 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,404 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.25 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,475 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,720 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,098 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 22.18 | ₹54 Cr | — | -1.68 | -8.63 | -₹26 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
| ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr |
| ₹7 Cr | ₹33 Cr | ₹32 Cr | ₹30 Cr | ₹35 Cr | ₹35 Cr |
| ₹7 Cr | ₹33 Cr | ₹32 Cr | ₹30 Cr | ₹35 Cr | ₹35 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹3 L |
| ₹32 Cr | ₹58 Cr | ₹57 Cr | ₹55 Cr | ₹58 Cr | ₹58 Cr |
| ₹0 | ₹14 Cr | ₹19 Cr | ₹27 Cr | ₹27 Cr | ₹33 Cr |
| ₹7 Cr | ₹13 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹13 Cr |
| ₹53 L | ₹51 L | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| ₹1 Cr | ₹8 Cr | ₹6 Cr | ₹57 L | ₹87 L | ₹2 Cr |
| ₹77 L | ₹1 Cr | ₹91 L | ₹82 L | ₹75 L | ₹62 L |
| ₹9 Cr | ₹37 Cr | ₹38 Cr | ₹41 Cr | ₹41 Cr | ₹50 Cr |
| — | — | — | — | — | — |
| ₹42 Cr | ₹31 Cr | ₹27 Cr | ₹35 Cr | ₹21 Cr | ₹16 Cr |
| ₹43 Cr | ₹13 Cr | ₹16 Cr | ₹12 Cr | ₹15 Cr | ₹10 Cr |
| ₹29 Cr | ₹22 Cr | ₹21 Cr | ₹21 Cr | ₹22 Cr | ₹21 Cr |
| ₹1 Cr | ₹60 L | ₹73 L | ₹48 L | ₹83 L | ₹54 L |
| ₹114 Cr | ₹66 Cr | ₹65 Cr | ₹69 Cr | ₹58 Cr | ₹48 Cr |
| ₹156 Cr | ₹161 Cr | ₹160 Cr | ₹166 Cr | ₹157 Cr | ₹157 Cr |
| ₹55 Cr | ₹56 Cr | ₹61 Cr | ₹63 Cr | ₹70 Cr | ₹73 Cr |
| — | — | — | — | — | — |
| ₹70 Cr | ₹70 Cr | ₹70 Cr | ₹70 Cr | ₹52 Cr | ₹52 Cr |
| ₹35 Cr | ₹30 Cr | ₹26 Cr | ₹20 Cr | ₹16 Cr | ₹12 Cr |
| ₹35 Cr | ₹39 Cr | ₹45 Cr | ₹50 Cr | ₹37 Cr | ₹39 Cr |
| ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹13 Cr | ₹26 Cr | ₹25 Cr |
| ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹16 Cr | ₹20 Cr | ₹24 Cr |
| ₹3 L | ₹0 | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹68 Cr | ₹71 Cr | ₹76 Cr | ₹84 Cr | ₹88 Cr | ₹94 Cr |
| — | — | — | — | — | — |
| ₹26 Cr | ₹41 Cr | ₹37 Cr | ₹39 Cr | ₹31 Cr | ₹20 Cr |
| ₹17 Cr | ₹20 Cr | ₹26 Cr | ₹27 Cr | ₹19 Cr | ₹20 Cr |
| ₹18 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr |
| ₹6 L | ₹5 L | ₹7 L | ₹8 L | ₹43 L | ₹6 Cr |
| ₹10 Cr | ₹9 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹6 Cr |
| ₹71 Cr | ₹72 Cr | ₹74 Cr | ₹79 Cr | ₹63 Cr | ₹54 Cr |
| -₹44 Cr | ₹6 Cr | ₹9 Cr | ₹10 Cr | ₹6 Cr | ₹6 Cr |
| ₹17 Cr | ₹18 Cr | ₹10 Cr | ₹3 Cr | ₹5 Cr | ₹8 Cr |
| ₹156 Cr | ₹161 Cr | ₹160 Cr | ₹166 Cr | ₹157 Cr | ₹157 Cr |
| ₹6 | ₹16 | ₹19 | ₹21 | ₹23 | ₹22 |
| ₹6 | ₹16 | ₹19 | ₹21 | ₹23 | ₹22 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| -₹26 Cr | ₹85 L | ₹2 Cr | -₹6 Cr | ₹5 L | -₹4 Cr |
| ₹7 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr |
| ₹40 Cr | ₹78 L | -₹7 Cr | ₹4 Cr | -₹5 Cr | -₹15 Cr |
| ₹21 Cr | ₹12 Cr | ₹5 Cr | ₹9 Cr | ₹6 Cr | -₹7 Cr |
| ₹21 Cr | ₹12 Cr | ₹5 Cr | ₹9 Cr | ₹6 Cr | -₹7 Cr |
| -₹25 L | -₹1 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr | -₹27 Cr |
| -₹4 Cr | -₹10 Cr | -₹7 Cr | -₹11 Cr | -₹10 Cr | ₹36 Cr |
| ₹17 Cr | -₹14 L | -₹1 L | -₹98 L | -₹1 Cr | ₹1 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| ₹18 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr |
Fundamental Ratios
Consolidated
Standalone
Cian Healthcare Share Price
22.18+0.43 (+1.98%)
+392.89% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 3 out of 9 oscillators
RSI
98.28Buy
STOCH %K
100.00Sell
MACD Level(12,26)
3.60Buy
Ultimate Oscillator
99.72Buy
Aroon Oscillator
84.00Buy
BOP
0.00Neutral
CCI
136.25Sell
Williams %R
0.00Sell
Momentum
10.59Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
19.06Buy
SMA 9
18.88Buy
EMA 21
15.45Buy
SMA 21
14.64Buy
EMA 50
11.32Buy
SMA 50
9.27Buy
EMA 200
7.19Buy
SMA 200
5.65Buy
WMA 20
17.17Buy
Pivot
Pivot
Classic
Resistance 5
21.75
Resistance 4
21.75
Resistance 3
21.75
Resistance 2
21.75
Resistance 1
21.75
Pivot
21.75
Support 1
21.75
Support 2
21.75
Support 3
21.75
Support 4
21.75
Support 5
21.75
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Cian Healthcare Share Price
22.18+0.43 (+1.98%)
+392.89% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|
| 95.00% | 95.00% | 27.10% | 27.10% | 27.10% | 27.10% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 5.00% | 5.00% | 72.90% | 72.90% | 72.90% | 72.90% |
Bulk & block deals
Name
Raj Breeders And Hatcheries Private Limited
Pravin Brijvallabha Chandak
Anand Mohan .
Nikunj Ghanshyam Chandak
Kanta Devi Samdaria
Pradeepchowdaryveeramachineni
Guttikonda Vara Lakshmi
Guttikonda Rajasekhar
Sumantekriwal
Krishna Murari Tekriwal
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 30 Dec 2025 | Purchase | 8.07 L | ₹5.38 | 1.50 L | Bulk | 0.6 | BSE |
| 22 Dec 2025 | Purchase | 14.16 L | ₹4.72 | 3 L | Bulk | 1.2 | BSE |
| 22 Dec 2025 | Purchase | 9.44 L | ₹4.72 | 2 L | Bulk | 0.8 | BSE |
| 22 Dec 2025 | Purchase | 7.82 L | ₹4.77 | 1.64 L | Bulk | 0.656 | BSE |
| 22 Dec 2025 | Sell | 16.71 L | ₹4.72 | 3.54 L | Bulk | 1.416 | BSE |
| 07 Nov 2025 | Purchase | 9.90 L | ₹7.50 | 1.32 L | Bulk | 0.528 | BSE |
| 04 Nov 2025 | Purchase | 12.53 L | ₹7.37 | 1.70 L | Bulk | 0.68 | BSE |
| 07 Oct 2025 | Purchase | 25.55 L | ₹4.99 | 5.12 L | Bulk | 2.048 | BSE |
| 30 Jun 2025 | Purchase | 5.48 L | ₹4.15 | 1.32 L | Bulk | 0.528 | BSE |
| 30 Jun 2025 | Sell | 5.48 L | ₹4.15 | 1.32 L | Bulk | 0.528 | BSE |
Insider trading & SAST
Client name
Ananta Medicare Ltd & Pacs
Pradeep Kumar Jain & Pacs
Rajesh Jain & Pacs
Suraj Sriniwas Zanwar
Pankaj Shriniwas Zanwar
Kavita Suraj Zanwar
Suraj Shriniwas Zanwar
Suraj Shriniwas Zanwar
Kavita Suraj Zanwar
Kavita Suraj Zanwar
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 Apr 2026 | Promoter | Acquisition | 95 | 95 | 0 | — | 2.38 Cr | 16 Mar 2026 | Pref. Allotment | 2,37,50,000 | SAST | 29(1) | — |
| 10 Apr 2026 | Promoter | Acquisition | 95 | 95 | 0 | — | 2.38 Cr | 16 Mar 2026 | Pref. Allotment | 2,37,50,000 | SAST | 29(1) | — |
| 10 Apr 2026 | Promoter | Acquisition | 95 | 95 | 0 | — | 2.38 Cr | 16 Mar 2026 | Pref. Allotment | 2,37,50,000 | SAST | 29(1) | — |
| 15 Jun 2024 | Promoter | Disposal | 2.8 | 11.36 | 0 | — | 7 L | 18 Jan 2024 | Market | 28,39,847 | SAST | 29(2) | — |
| 15 Jun 2024 | Promoter | Disposal | 2.96 | 13.84 | 0 | — | 7.40 L | 06 Feb 2024 | Market | 34,60,000 | SAST | 29(2) | — |
| 15 Jun 2024 | Promoter | Disposal | 3.2 | 1.49 | 0 | — | 8 L | 10 Jan 2024 | Market | 3,72,000 | SAST | 29(2) | — |
| 18 Jan 2024 | Promoter | Disposal | 6.089023 | 14.14 | 2.89 Cr | ₹19 | 15.22 L | 11 Jan 2024 - 15 Jan 2024 | Market Sale | 35,35,847 | Insider Trading | — | Equity Shares |
| 12 Jan 2024 | Promoter | Disposal | 1.200202 | 20.23 | 52.80 L | ₹17.60 | 3 L | 10 Jan 2024 | Market Sale | 50,57,847 | Insider Trading | — | Equity Shares |
| 12 Jan 2024 | Promoter | Disposal | 3.432577 | 1.42 | 1.51 Cr | ₹17.60 | 8.58 L | 01 Jan 2024 - 10 Jan 2024 | Market Sale | 3,56,000 | Insider Trading | — | Equity Shares |
| 02 Jan 2024 | Promoter | Disposal | 4.200706 | 4.86 | 2.06 Cr | ₹19.65 | 10.50 L | 01 Oct 2023 - 31 Dec 2023 | Market Sale | 12,14,000 | Insider Trading | — | Equity Shares |
Cian Healthcare Share Price
22.18+0.43 (+1.98%)
+392.89% past 1 Year
Cian Healthcare Limited develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology,
Corporate Actions
Date
Type
Details
Company details
Cian Healthcare Share Price
22.18+0.43 (+1.98%)
+392.89% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Cian Healthcare Share Price
22.18+0.43 (+1.98%)
+392.89% past 1 Year
News
Cian Healthcare submits board meeting intimation
Equity
CHCL
Cian Healthcare informs about newspaper publication
Equity
CHCL
Cian Healthcare informs about update on CoC
Equity
CHCL
Cian Healthcare informs about outcome of AGM
Equity
CHCL
Cian Healthcare informs about change in corporate office address
Equity
CHCL
Cian Healthcare informs about published announcement
Equity
CHCL
Cian Healthcare informs about disclosure
Equity
CHCL
Cian Healthcare informs about receipt of adjudication order of penalties
Equity
CHCL
Cian Healthcare informs about disclosure
Equity
CHCL
Cian Healthcare jumps on entering into agreement with HLL Lifecare
Equity
CHCL
Cian Healthcare enters into agreement with HLL Lifecare
Equity
CHCL
Cian Healthcare informs about disclosure
Equity
CHCL
Cian Healthcare informs about disclosure
Equity
CHCL
Cian Healthcare informs about appointment of additional director
Equity
CHCL
Cian Healthcare inks merchant export agreement with Tamil Pharma
Equity
CHCL
Cian Healthcare informs about disclosure
Equity
CHCL
Cian Healthcare zooms on entering into agreement with CHI Pharmaceuticals, Nigeria
Equity
CHCL
Cian Healthcare enters into agreement with CHI Pharmaceuticals, Nigeria
Equity
CHCL
Cian Healthcare informs about board meeting
Equity
CHCL


